How are energy investors positioned?
Sanuwave Health, Inc . (NASDAQ:SNWV) announced Thursday that it has received a $5 million cash payment from a third-party licensee following the exercise of an option to acquire a portfolio of Sanuwave patents related to intravascular shockwave applications. The information is based on a statement in the company’s SEC filing.
According to the filing, Sanuwave previously entered into an exclusive license and option agreement with the licensee on March 6, 2024. Under the original agreement, Sanuwave granted the licensee exclusive rights to the patents and an option to purchase them in exchange for a one-time payment of $2.5 million.
On Thursday, the licensee exercised the option to acquire the patents, resulting in the $5 million payment to Sanuwave. The company’s common stock is listed on the Nasdaq Stock Market under the symbol SNWV.
No additional details regarding the identity of the licensee or the specific patents involved were disclosed in the filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.